8-KOther EventsExhibits & Filings

UNITEDHEALTH GROUP INC 8-K Report, Corporate Update (Jun 20, 2025)

Filed June 20, 2025For Securities:UNH

Summary

UnitedHealth Group Inc. (UNH) has filed an 8-K report detailing the issuance of $3.5 billion in aggregate principal amount of senior notes. This debt offering comprises four tranches with varying interest rates and maturity dates, ranging from 2028 to 2055. The issuance was facilitated through an Underwriting Agreement and Pricing Agreement with a syndicate of major investment banks, including BofA Securities, Barclays Capital, Citigroup Global Markets, and J.P. Morgan Securities. This debt issuance diversifies UNH's capital structure and provides funds that can be utilized for general corporate purposes, potential acquisitions, or to refinance existing debt. Investors should note the different coupon rates and maturity profiles, which may appeal to a range of risk appetites and investment horizons. The registration of these notes under the Securities Act of 1933, via a Form S-3 shelf registration statement, indicates a routine capital markets transaction for a company of UNH's stature.

Key Highlights

  • 1UnitedHealth Group Inc. issued $3.5 billion in aggregate principal amount of senior notes.
  • 2The offering consists of four tranches with maturities in 2028, 2031, 2035, and 2055.
  • 3Interest rates for the notes range from 4.400% to 5.950%.
  • 4The issuance was conducted under standard underwriting and pricing agreements with prominent investment banks.
  • 5The notes are registered under the Securities Act of 1933 through an automatic shelf registration statement.
  • 6This move allows UNH to access capital markets for corporate funding needs.

Frequently Asked Questions

UnitedHealth Group issued a total of $3.5 billion in aggregate principal amount of senior notes across four different series.

The notes have the following maturities and interest rates: 4.400% Notes due June 15, 2028 ($500 million), 4.650% Notes due January 15, 2031 ($750 million), 5.300% Notes due June 15, 2035 ($1,000 million), and 5.950% Notes due June 15, 2055 ($750 million).

The filing states that the proceeds will be used for general corporate purposes, which can include a variety of uses such as funding operations, capital expenditures, potential acquisitions, or refinancing existing debt. Specific use of proceeds is not detailed in this 8-K.

This 8-K filing reports on the material event of issuing new debt securities. It also serves to file as exhibits certain agreements and documents related to this note issuance, which will be incorporated by reference into the company's existing shelf registration statement.